150 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals, Inc.
17 Jul 24
Processa Pharmaceuticals Names Russell L. Skibsted as Chief Financial Officer
8:00am
to such dependents immediately prior to the date of such Separation Event. The Executive will be responsible for any portion of the premium associated … with such coverage that he was responsible for during employment. If the Company is not reasonably able to continue health insurance benefits coverage
8-K
EX-4.1
bvhs8rx
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
8-K
EX-4.2
nbjpryvxj 12rf237
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
8-K
EX-4.3
7u1a5u gd7xb14
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
8-K
EX-10.1
epd3pj24ia 7d
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
UPLOAD
jaculjbsugzx
5 Jan 24
Letter from SEC
12:00am